Calgary, Canada

Jillian Hagel

This inventor holds 1 USPTO granted patent. Top assignee: Willow Biosciences, Inc.. Active years: 2020.


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jillian Hagel in Alkaloid Compounds

Introduction

Jillian Hagel is a prominent inventor based in Calgary, Canada. She has made significant contributions to the field of chemistry, particularly in the development of methods for synthesizing alkaloid compounds. Her work focuses on the production of ephedrine and its derivatives, which have important applications in medicine.

Latest Patents

Jillian holds a patent for "Methods and compositions for making ephedrine and related alkaloid compounds." This patent outlines innovative methods for creating alkaloid compounds, including ephedrine, through an N-methyltransferase catalyzed chemical reaction. Her patent represents a significant advancement in the synthesis of these important compounds.

Career Highlights

Jillian is currently employed at Willow Biosciences, Inc., where she continues to explore and develop new methodologies in the field of biochemistry. Her expertise and innovative approach have positioned her as a valuable asset to her team and the broader scientific community.

Collaborations

Jillian collaborates with Peter James Facchini, a fellow researcher, to further enhance their understanding and capabilities in the synthesis of alkaloid compounds. Their partnership exemplifies the importance of teamwork in advancing scientific research.

Conclusion

Jillian Hagel's contributions to the field of alkaloid synthesis highlight her innovative spirit and dedication to scientific advancement. Her work not only furthers our understanding of chemical processes but also has the potential to impact various applications in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…